To Serve PatientsAmgen strives to serve patients by transforming the promise of science and biotechn...
Board-certified internist/gastroenterologist with long-standing clinical and scientific expertise in gastrointestinal oncology. Completed postdoctoral fellowship at the Department of Gene and Cell Medicine at Mount Sinai School of Medicine in New York, USA, subsequently appointed as an Assistant Professor for research on oncolytic virotherapy of hepatocellular carcinoma. Senior attending physician and research group leader at Technische Universität München, Germany for several years before joining AMGEN GmbH as Medical Development Director in 2016. Published over 40 peer-reviewed manuscripts and recipient of several research grants and recognitions, including Molecular Therapy – Oncolytics editorial board membership.